NCT07562672

Brief Summary

This study tests whether a traditional Chinese herbal bath called Tongyangxiao (TYX) lotion helps surgical wounds heal faster in patients who have had anal fistula surgery. Anal fistulas are abnormal tunnels near the anus that often require surgery, but the wound is usually left open and heals slowly. The study compares TYX lotion with a standard antiseptic bath (potassium permanganate). Patients use one of the two baths once daily for 14 days after surgery. The main goal is to see how long it takes for the wound to close completely. The study also measures pain, wound size, inflammation, and proteins involved in healing. A total of 115 patients took part, and laboratory experiments with human skin cells were also performed to understand how TYX works.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
115

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

April 26, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 1, 2026

Completed
Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

1.1 years

First QC Date

April 26, 2026

Last Update Submit

April 26, 2026

Conditions

Keywords

Tongyangxiao Lotion; Anal fistula; Wound Healing; PI3K-Akt-mTOR signaling pathway; Traditional Chinese medicine

Outcome Measures

Primary Outcomes (1)

  • Wound healing time

    Number of days from surgery to complete wound closure (complete epithelialization without need for dressing).Time Frame

    From date of surgery until complete epithelialization, assessed daily up to 60 days

Secondary Outcomes (6)

  • Wound area

    Postoperative days 5, 7, and 14

  • Exudate score

    Postoperative days 5, 7, and 14

  • Pain score (VAS)

    Postoperative days 5, 10, and 14

  • Inflammatory cytokines (TNF-α, IL-6, IL-1β)

    Postoperative days 7 and 14

  • PI3K-Akt-mTOR pathway proteins (p-PI3K, p-Akt, p-mTOR)

    Postoperative days 7 and 14

  • +1 more secondary outcomes

Study Arms (2)

Tongyangxiao (TYX) group

EXPERIMENTAL

Patients receive a 15-minute sitz bath once daily with 1500 mL of Tongyangxiao decoction (40°C) from postoperative day 2 for 14 consecutive days. The decoction contains ten herbs: Huangbai (Phellodendron chinense), Kushen (Sophora flavescens), Danggui (Angelica sinensis), Cangzhu (Atractylodes lancea), Qinjiao (Gentiana macrophylla), Xixin (Asarum sieboldii), Fangfeng (Saposhnikovia divaricata), Chuanjiao (Zanthoxylum bungeanum), Mingfan (Alumen), and Mangxiao (Natrii Sulfas).

Other: Tongyangxiao (TYX) groupOther: Potassium permanganate (PP) group

Potassium permanganate (PP) group

ACTIVE COMPARATOR

Patients receive a 15-minute sitz bath once daily with 1500 mL of 1:5000 potassium permanganate solution (40°C) from postoperative day 2 for 14 consecutive days.

Other: Tongyangxiao (TYX) groupOther: Potassium permanganate (PP) group

Interventions

Patients receive a 15-minute sitz bath once daily with 1500 mL of Tongyangxiao decoction (40°C) from postoperative day 2 for 14 consecutive days. The decoction contains ten herbs: Huangbai (Phellodendron chinense), Kushen (Sophora flavescens), Danggui (Angelica sinensis), Cangzhu (Atractylodes lancea), Qinjiao (Gentiana macrophylla), Xixin (Asarum sieboldii), Fangfeng (Saposhnikovia divaricata), Chuanjiao (Zanthoxylum bungeanum), Mingfan (Alumen), and Mangxiao (Natrii Sulfas).

Potassium permanganate (PP) groupTongyangxiao (TYX) group

atients receive a 15-minute sitz bath once daily with 1500 mL of 1:5000 potassium permanganate solution (40°C) from postoperative day 2 for 14 consecutive days.

Also known as: Active Comparator
Potassium permanganate (PP) groupTongyangxiao (TYX) group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 to 65 years
  • Diagnosis of low simple anal fistula according to the Chinese expert consensus on diagnosis and treatment of anal fistula (2020 edition)
  • Traditional Chinese medicine pattern of damp-heat downward infusion
  • Underwent low anal fistulectomy
  • No surgical contraindications

You may not qualify if:

  • Complex or high anal fistula
  • Inflammatory bowel disease, diabetes mellitus, or severe cardiac / liver / renal dysfunction
  • Allergy to any component of Tongyangxiao lotion or potassium permanganate
  • Pregnancy or lactation
  • Participation in another clinical trial within 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the First Affiliated Hospital of Henan University of Chinese Medicine

Zhengzhou, Henan, 450000,, China

Location

MeSH Terms

Conditions

Rectal Fistula

Interventions

Population GroupsPotassium Permanganate

Condition Hierarchy (Ancestors)

Intestinal FistulaDigestive System FistulaDigestive System DiseasesIntestinal DiseasesGastrointestinal DiseasesRectal DiseasesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

DemographyPopulation CharacteristicsManganese CompoundsInorganic ChemicalsPotassium Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Chief Physician

Study Record Dates

First Submitted

April 26, 2026

First Posted

May 1, 2026

Study Start

June 1, 2023

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations